Article: Market Assessment Underway by PTSC to Complement Strong Product Review.

Patriot Scientific Corporation (BULLETIN BOARD: PTSC) announced that Eclat Consulting, LLC, ("Eclat") will launch a market validation study of the Company's flagship technology, the Crossflo DataExchange[R] platform ("CDX"). This follows on the heels of a completed independent assessment conducted by a Fortune 1000 technology firm in which CDX scored very high marks in all significant categories including product stability, code quality, and overall design rigor.

The Eclat team, lead by CEO Greg Baroni, recently assisted the Company with an assessment of key management, and has also been working with the Company to identify strategic options for the Company's ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!